Powered by

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials; PolyVascular Hires Will Clifton, MD, as COO to Manage Path to Human Trials in US; Ultimate Goal to Help

Mar 30, 2021 - PR Newswire
Board and Executive Moves

PR Newswire

HOUSTON, March 30, 2021 /PRNewswire-PRWeb/ -- PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve (PTV) for children, announced today that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million...